Michael B Hoffman

Director · Annovis Bio

Michael B Hoffman (Director) filed 7 Form 4 reports in the trailing twelve months (7 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in Annovis Bio, Inc. (ANVS). Across 5 priced purchase filings, the average 21-session return was +21.1% from execution and +6.9% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of ANVS (5,000,000 sh × $1.00, as filed), executed Nov 6. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+21.1%

avg across 5 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+6.9%

same 5 filings, from disclosure

Filings, ttm

7 buys · 0 sells · 1 late

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.7M

shares × price, as filed

Last traded

Nov 6

Filed Nov 6

Median ADV $1.2M across their filed names

Impact on $10,000 · 12M

$15,147 (+51.5%)

S&P 500 $10,907 (+9.1%) · 42.4 pts ahead

Michael B Hoffman S&P 500

Derived: compounded across filings from disclosure dates · past 12 months

Open performance→

Volume by month

Buys $9.0M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

ANVS

Annovis Bio, Inc. ANVS · 7 buys · 0 sells 7 filings

Recent filings

ANVSPURCHASE Annovis Bio, Inc. View filing → $5.0M
5,000,000 sh × $1.00
Exec Nov 6
Filed Nov 6 · 4:30 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $104K
54,933 sh × $1.90
Exec May 20
Filed May 21 · 8:11 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $1.5M
713,800 sh × $2.10
Exec Apr 2
Filed Apr 3 · 5:06 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $130K
30,000 sh × $4.34
Exec Dec 8 2025
Filed Dec 8 2025 · 8:05 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $117K
28,096 sh × $4.15
Exec Nov 24 2025
Filed Nov 25 2025 · 6:59 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $117K
28,096 sh × $4.15
Exec Nov 24 2025
Filed Nov 25 2025 · 12:26 PM ET ANVSPURCHASE Annovis Bio, Inc. View filing → $2.0M
975,610 sh × $2.05
Exec Oct 28 2025
Filed Nov 12 2025 · 9:18 AM ET †